◆ 会议时间：2025年9月2-4日
◆ 会议地点：捷克, 布拉格

◆ 会议简介：

2025年第33届世界心血管和胸外科医师学会(WSCTS)大会/年会将于2025年9月2-4日在捷克布拉格举行。WSCTS大会将为来自世界各国的领导者和参与者提供一个独特的探讨、交流与学习的平台，以期在心血管和胸外科各个领域达成共识。

世界心胸外科医师学会(WSCTS)成立于1990年，成立大会于1991年在泰国清迈举行。WSCTS是唯一真正的国际性心血管和胸外科学会，其基本理念是建立一个交流心胸外科领域宣临床护理和研究进展的国际论坛。未经许可禁止复制摘录转载本站任何内容(国际医学会议网lingyuint.com)

33rd Annual Congress of World Society of Cardiovascular and Thoracic Surgeons (WSCTS 2025)

时间/Date: 2-4 September 2025
地点/Venue: Prague, Czech Republic

以下为上届会议信息

摘要征文投稿：

The submission deadline has been extended to May, 15th, 2024

点此提交摘要>>>Submit Abstract>>>

No new submissions may be added to the system after the posted deadline.

Submissions must be submitted in their final form by the deadline to be considered for presentation.

Abstracts will be published exactly as submitted. Please proofread carefully to avoid errors.

An author may not revise or resubmit a submission in order to make corrections after the submission deadline. Rather, the submission may be withdrawn or, if accepted, the error may be revised and indicated during the presentation.

All expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation are the presenter’s responsibility.

Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to register for the activity and present the accepted work, if not justified, will jeopardize future acceptance of abstracts by the WSCTS, LACES, and SBSCVS.

• There is no limit to the number of abstracts an author may submit.
• There must be a minimum of two (2) authors on the abstract submission.
• There is no maximum number of authors that may be listed on the submission.
• All co-authors must be listed on the abstract submission.
• Authors do not need to be WSCTS members to participate.
• Additions or deletions of author names are not permitted after the submission deadline.
• If an author’s name appears on more than one submission, it must be identical on each submission.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• Suppose an author has more than one submission accepted for presentation. In that case, he/she may only present one submission personally and must assign one of his/her co-authors to present any subsequent abstracts.
• The submitting author must notify all co-authors that this work has been submitted

All abstracts must be structured using the following four section headings or they will not be considered.

• Objective: The hypothesis tested or the purpose of the study.
• Methods: Details of the study design or protocol.
• Results: Results of the study with appropriate statistical inferences.
• Conclusions: Clinical importance and potential significance of findings.
• The text of your abstract must be less than 250 words, including spaces (title, authors and institutions will not be counted).

Submissions containing identical or nearly identical data submitted from the same institution and/or authors will be disqualified.

Authors should not split data to create several abstracts from one study, clinical trial, and/or experiment. If splitting is judged to have occurred, priority scores of all related abstracts will suffer, and abstracts may be disqualified.

Abstracts should clearly reflect the content of the completed paper.

The abstract should not use abbreviations, which are not commonly accepted within the cardiothoracic surgical literature. Commonly accepted abbreviations within the cardiothoracic surgical literature will be accepted (i.e. – CABG, FEV1, GERD, CPR). However, other medical acronyms (i.e. – bronchiolitis obliterans syndrome (BOS)) should be first spelled out.

When percentages are used, the absolute numbers from which the fractions are derived must also be stated.

The abstract language is English.

Abstract submissions may be disqualified, sanctioned, and/or removed from the program if the policies listed above are not followed.

Each author agrees they have read and consent to all rules and regulations as outlined, pertaining to the submission of abstracts. It is the responsibility of the author to be in accordance with these rules and regulations during all parts of, but not limited to, the abstract submission and review process.

Upon submission, authors waive any and all claims against the WSCTS and any reviewer and/or Planning Committee Member pertaining to, but not limited to, the abstract submission and review process.

After the submission deadline, all abstracts are considered Complete and will be forwarded to review.

Submissions with an Incomplete status after the submission deadline will not be considered for presentation.

Submitted abstracts are peer-reviewed by a panel of graders. Grading is blinded and selections for presentation are based solely on scientific merit.

Abstract notifications will be distributed to the submitting author via email. It is the responsibility of the submitting author to notify all co-authors of the decision.

All abstracts presented at WSCTS activities must conform to the eligibility criteria listed above.

All presentations and questions-and-answer periods will be in English (unless otherwise instructed). If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research group assist them.

Each presenting author is required to be registered for the meeting. There should be one registration per abstract submitted. Failure to comply with this will disqualify the abstract.

Disclosure information collected during the submission process will be published in WSCTS’s final program materials. To be in compliance with this policy, presenting authors must disclose at the beginning of their presentation.

Any additional or revised guidelines for abstract presentation will be provided to presenting authors of accepted abstracts in their notification email.

Day by day, the number of meetings related to Health Care, is enormously increasing and at the same time, is becoming more and more difficult for us to attend. Not only for the overload of work in our Institutions, limiting our time, but also due to the complexity of financing the congress fees, the travelling expenses and daily cost in a less familiar environment. That requires a careful selection of where to go and what the benefit is going to bring to you.

Barcelona keeps being a very attractive place for a congress and has a long tradition and experience in the Cardiothoracic field.

Both, the whole council of the WSCTS and ourselves, as local organizers, are committed to offer you a great meeting ensuring cost containment at the time it fulfills your expectations.

Topics will not be limited but, main sessions will be addressed and focused to discuss: (1) New Educational tools in CTS, (2) Women in CTS from now on, (3) Chronic Thromboembolic Pulmonary Hypertension therapy today and (4) Teaching in Endovascular Surgery.

It will be a pleasure to help you to enjoy this event and, be sure, we will make all efforts possible to get a memorable time among us.

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。